1.
Mariani G, Guidi L, Barioglio A. Olanzapine versus typical neuroleptics for schizophrenia: evaluation of social and economic costs. FE [Internet]. 2006 Sep. 15 [cited 2026 May 17];7(2):119-24. Available from: https://journals.seedstm.com/index.php/FE/article/view/681